Thursday, November 12, 2026
Get the IHR NewsletterSubscribe

Loblaw Reports 2022 Second Quarter Results

By IHR Magazine, . Updated

Loblaw delivered strong operational and financial results as it continued to execute on retail excellence in its core businesses while advancing its growth and efficiencies initiatives. Drug Retail performance continued to drive overall margin expansion, as sales benefited from growth in higher margin front-store categories.

The positive trend in Food Retail continued with the Company’s conventional stores performing well relative to peers and sales growth in its discount banners, heightened by the strength of the No Frills® and Maxi® hard-discount stores and the Company’s value-focused control brand no name®.

“Loblaw delivered consistent operating and financial results, as customers recognized the value, quality and convenience delivered through our diverse store formats, control brand products, and our PC Optimum loyalty program,” said Galen G. Weston, Chairman and President, Loblaw Companies Limited. “In the quarter we also continued to pursue our strategic growth agenda, with the completion of our acquisition of Lifemark Health Group, bolstering our healthcare services offering and furthering our purpose to help Canadians Live Life Well.”

2022 SECOND QUARTER HIGHLIGHTS

See “News Release Endnotes” at the end of this News Release.

CONSOLIDATED AND SEGMENT RESULTS OF OPERATIONS

The following tables provide key performance metrics for the Company by segment and same-store sales.

Sections: Retail News

More in Retail News